Restricted Albumin Utilization Is Safe and Cost Effective in a Cardiac Surgery Intensive Care Unit

2016/12/24 by Joseph Rabin, Timothy Meyenburg, Ashleigh Lowery +4 · 11 citations
Medicine · #Trauma, Hemostasis, Coagulopathy, Resuscitation #Blood transfusion and management #Sepsis Diagnosis and Treatment

paper · pdf · doi:10.1016/j.athoracsur.2016.10.018

Cited by

• Evaluation of Albumin 25% Use in Critically Ill Patients at a Tertiary Care Medical Center. [europepmc]
• Application of Unit-Level Cost Transparency, Education, Enhanced Audit, and Feedback of Anonymized Peer Ranking to Promote Judicious Use of 25% Albumin in Critical Care Units. [europepmc]
• Albumin Use After Cardiac Surgery. [europepmc]
• Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study. [europepmc]
• Single-Center Experience of Outcomes and Prescribing Patterns of IV Immunoglobulin Use in Critically Ill Patients. [europepmc]
• STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management. [europepmc]
• Preoperative serum albumin: a promising indicator of early mortality after surgery for infective endocarditis. [europepmc]
• Expert consensus on the use of human serum albumin in adult cardiac surgery. [europepmc]
• Reduce intraoperative albumin utilisation in cardiac surgical patients: a quality improvement initiative. [europepmc]
• Risk factors and predictive nomogram of human serum albumin infusion after total hip arthroplasty for femoral head necrosis. [europepmc]
• Management of Liver Cirrhosis in Percutaneous and Surgical Cardiac Interventions. [europepmc]